Robert Hershberg is of HilleVax, Inc.. Currently has a direct ownership of 953,831 shares of HLVX, which is worth approximately $1.72 Million. The most recent transaction as insider was on Feb 08, 2024, when has been sold 11,597 shares (Common Stock) at a price of $14.93 per share, resulting in proceeds of $173,143. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 954K
0% 3M change
1.2% 12M change
Total Value Held $1.72 Million

ROBERT HERSHBERG Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 08 2024
SELL
Open market or private sale
$173,143 $14.93 p/Share
11,597 Reduced 1.2%
953,831 Common Stock
Feb 08 2024
BUY
Grant, award, or other acquisition
-
174,202 Added 13.38%
1,128,033 Common Stock
Feb 01 2023
BUY
Grant, award, or other acquisition
-
187,966 Added 16.3%
965,428 Common Stock

Also insider at

ADPT
Adaptive Biotechnologies Corp Healthcare
NSTG
NanoString Technologies Inc Healthcare
SBTX
Silverback Therapeutics, Inc. Healthcare
RXRX
RECURSION PHARMACEUTICALS, INC. Healthcare
FATE
FATE THERAPEUTICS INC Healthcare
RH

Robert Hershberg

San Diego, CA

Track Institutional and Insider Activities on HLVX

Follow HilleVax, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HLVX shares.

Notify only if

Insider Trading

Get notified when an Hille Vax, Inc. insider buys or sells HLVX shares.

Notify only if

News

Receive news related to HilleVax, Inc.

Track Activities on HLVX